IBDEI0GB ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7316,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,7316,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,7317,0)
 ;;=I10.^^36^365^45
 ;;^UTILITY(U,$J,358.3,7317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7317,1,3,0)
 ;;=3^Hypertension (Essential)
 ;;^UTILITY(U,$J,358.3,7317,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,7317,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,7318,0)
 ;;=R09.02^^36^365^48
 ;;^UTILITY(U,$J,358.3,7318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7318,1,3,0)
 ;;=3^Hypoxemia
 ;;^UTILITY(U,$J,358.3,7318,1,4,0)
 ;;=4^R09.02
 ;;^UTILITY(U,$J,358.3,7318,2)
 ;;=^332831
 ;;^UTILITY(U,$J,358.3,7319,0)
 ;;=Z59.6^^36^365^49
 ;;^UTILITY(U,$J,358.3,7319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7319,1,3,0)
 ;;=3^Low income
 ;;^UTILITY(U,$J,358.3,7319,1,4,0)
 ;;=4^Z59.6
 ;;^UTILITY(U,$J,358.3,7319,2)
 ;;=^5063135
 ;;^UTILITY(U,$J,358.3,7320,0)
 ;;=E88.81^^36^365^50
 ;;^UTILITY(U,$J,358.3,7320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7320,1,3,0)
 ;;=3^Metabolic syndrome
 ;;^UTILITY(U,$J,358.3,7320,1,4,0)
 ;;=4^E88.81
 ;;^UTILITY(U,$J,358.3,7320,2)
 ;;=^5003032
 ;;^UTILITY(U,$J,358.3,7321,0)
 ;;=E66.01^^36^365^51
 ;;^UTILITY(U,$J,358.3,7321,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7321,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,7321,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,7321,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,7322,0)
 ;;=E66.2^^36^365^52
 ;;^UTILITY(U,$J,358.3,7322,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7322,1,3,0)
 ;;=3^Morbid Obesity w/ Alveolar hypoventilation
 ;;^UTILITY(U,$J,358.3,7322,1,4,0)
 ;;=4^E66.2
 ;;^UTILITY(U,$J,358.3,7322,2)
 ;;=^5002829
 ;;^UTILITY(U,$J,358.3,7323,0)
 ;;=I25.2^^36^365^53
 ;;^UTILITY(U,$J,358.3,7323,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7323,1,3,0)
 ;;=3^Myocardial infarction,Hx of
 ;;^UTILITY(U,$J,358.3,7323,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,7323,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,7324,0)
 ;;=I21.4^^36^365^54
 ;;^UTILITY(U,$J,358.3,7324,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7324,1,3,0)
 ;;=3^Myocardial infarction,NSTEMI
 ;;^UTILITY(U,$J,358.3,7324,1,4,0)
 ;;=4^I21.4
 ;;^UTILITY(U,$J,358.3,7324,2)
 ;;=^5007088
 ;;^UTILITY(U,$J,358.3,7325,0)
 ;;=I21.3^^36^365^55
 ;;^UTILITY(U,$J,358.3,7325,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7325,1,3,0)
 ;;=3^Myocardial infarction,STEMI
 ;;^UTILITY(U,$J,358.3,7325,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,7325,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,7326,0)
 ;;=Z91.11^^36^365^56
 ;;^UTILITY(U,$J,358.3,7326,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7326,1,3,0)
 ;;=3^Noncompliance,Dietary regimen
 ;;^UTILITY(U,$J,358.3,7326,1,4,0)
 ;;=4^Z91.11
 ;;^UTILITY(U,$J,358.3,7326,2)
 ;;=^5063611
 ;;^UTILITY(U,$J,358.3,7327,0)
 ;;=Z91.19^^36^365^57
 ;;^UTILITY(U,$J,358.3,7327,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7327,1,3,0)
 ;;=3^Noncompliance,Medical treatment
 ;;^UTILITY(U,$J,358.3,7327,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,7327,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,7328,0)
 ;;=E66.9^^36^365^58
 ;;^UTILITY(U,$J,358.3,7328,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7328,1,3,0)
 ;;=3^Obesity
 ;;^UTILITY(U,$J,358.3,7328,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,7328,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,7329,0)
 ;;=G47.33^^36^365^59
 ;;^UTILITY(U,$J,358.3,7329,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7329,1,3,0)
 ;;=3^Obstructive sleep apnea 
